October 8, 2018
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.

 

NRG Oncology Research at ASTRO

The schedule of NRG Oncology research presentations is now available on the website.  Read More


AMENDMENTS
GYNECOLOGIC
NRG-GY003: Amendment 8; version date: September 7, 2018 (posted on CTSU).

OTHER PROTOCOL NOTICES
1. GENITOURINARY
NRG-GU006: The Spanish-translated consent form and CIRB approval of the form are available on the CTSU website.

2. GYNECOLOGIC
Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment

Please be advised that as of Monday, October 1, the data exchange between the Biospecimen Bank-Columbus and SDMC will be undergoing refurbishment. During this time, biospecimen receipt information will not appear in Rave or SEDES.

Biospecimen transmittal forms (i.e., Form SP and Form TR) will ultimately not appear as overdue during this time; however, there may be a brief period over the next several weeks during which forms may temporarily appear as overdue. If this should occur or if you experience any other issues, please notify Support ( support@nrgoncology.org).

Sites should continue to return inquiries from Biospecimen Bank-Columbus staff regarding biospecimen receipt during this time.

3. VTOC TRAINING
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003 and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for October 10, 2018.

 

DRUG SAFETY UPDATES
Safety updates have been issued for the following studies:

DRUG NAME

PROTOCOL

WEBSITE FOR SAFETY REPORTS

 Atezolimumab 

 NRG-GI004

 NRG-GY009

 CTSU

 CTSU

 Ipilimumab

 NRG-BN002

 NRG-GY003

 NRG

 NRG

 Nivolumab 

 NRG-BN002

 NRG-GY003

 NRG

 NRG

 Pembrolizumab 

 NRG-GY016

 NRG-HN003

 CTSU

 NRG




 

Living a Full Life interview with Drs. Curran and Abraham

Jame Abraham, MD, from the Cleveland Clinic and recently appointed to co-chair the NRG Oncology's Research Strategy Committee, was a guest editor for  The ASCO Post and interviewed Walter Curran, MD, one of NRG Oncology's group chairs, for the journal's  Living a Full Life series. In the interview, Dr. Curran reflects on his esteemed career in oncology and clinical trials research and the importance of identifying leadership qualities in young investigators to cultivate the best possible future leaders in oncology. Click  here to read the full interview.

NRG Oncology 2018 ASTRO Annual Meeting Presentation Schedule
The ASTRO Annual Meeting is being held October 21-24, 2018 in San Antonio, TX. The list of presentations by NRG Oncology researchers is posted on the 
NRG Oncology website.


NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES

Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M 3rd, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA. Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):287-295. doi: 10.1016/j.ijrobp.2018.06.008. Epub 2018 Jun 18. PubMed PMID: 29913254.  Read more

Seider MJ, Pugh SL, Langer C, Wyatt G, Demas W, Rashtian A, Clausen CL, Derdel JD, Cleary SF, Peters CA, Ramalingam A, Clarkson JE, Tomblyn M, Rabinovitch RA, Kachnic LA, Berk LB; NRG Oncology. Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial. Ann Nucl Med. 2018 Oct;32(8):553-560. doi: 10.1007/s12149-018-1278-4. Epub 2018 Aug 9. PubMed PMID: 30094545.   Read more


PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings

American Society for Radiation Oncology (ASTRO); Oct 21-24, 2018; San Antonio, TX

College of American Pathologists (CAP); Oct 20-24, 2018, Chicago, IL

European Society for Medical Oncology (ESMO); Oct 19-23, 2018; Munich, Germany

International Society for Quality of Life Research (ISOQOL); Oct 24-27, 2018; Dublin, Ireland

PA Breast Cancer Coalition (PBCC); October 19, 2018; Harrisburg, PA


Upcoming Abstract Submission Deadlines

American Association for Thoracic Surgery (AATS); May 4-7, 2019; Toronto, ON; due to publications committee Oct 16, 2018; meeting abstracts submission deadline Oct 30, 2018

American Head & Neck Society (AHNS); May 1-5, 2019; Austin, TX; due to publications committee Oct 12, 2018; meeting abstracts submission deadline Oct 26, 2018

American Society of Clinical Oncology (ASCO) GU; Feb 14-16, 2019; San Francisco, CA; due to publications committee Oct 9, 2018; meeting abstracts submission deadline Oct 23, 2018

American Society of Colon and Rectal Surgeons (ASCRS); Jun 1-5, 2019; Cleveland, OH; due to publications committee Nov 13, 2018; meeting abstracts submission deadline Nov 27

European Society for Radiotherapy and Oncology (ESTRO); Apr 26-30, 2019; Milan, Italy; due to publications committee Oct 8, 2018; meeting abstracts submission deadline Oct 22, 2018

Society of Gynecologic Oncology (SGO); Mar 16-19, 2019; Honolulu, HI; deadline for International abstracts  12-12-19; deadline for LBA 12-3-18 to 1-7-19


NRG Oncology is proud to be an active participant of #CancerMoonShot.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse